Acadia Pharmaceuticals Stock Price Patterns
| ACAD Stock | USD 25.13 0.57 2.22% |
Momentum 50
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 1.128 | EPS Estimate Next Quarter 0.1199 | EPS Estimate Current Year 0.8109 | EPS Estimate Next Year 0.7957 | Wall Street Target Price 31.0526 |
Using ACADIA Pharmaceuticals hype-based prediction, you can estimate the value of ACADIA Pharmaceuticals from the perspective of ACADIA Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ACADIA Pharmaceuticals using ACADIA Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards ACADIA using crowd psychology based on the activity and movement of ACADIA Pharmaceuticals' stock price.
ACADIA Pharmaceuticals Short Interest
A significant increase or decrease in ACADIA Pharmaceuticals' short interest from the previous month could be a good indicator of investor sentiment towards ACADIA. Short interest can provide insight into the potential direction of ACADIA Pharmaceuticals stock and how bullish or bearish investors feel about the market overall.
200 Day MA 22.8165 | Short Percent 0.0774 | Short Ratio 6.59 | Shares Short Prior Month 8.4 M | 50 Day MA 26.229 |
ACADIA Pharmaceuticals Hype to Price Pattern
Investor biases related to ACADIA Pharmaceuticals' public news can be used to forecast risks associated with an investment in ACADIA. The trend in average sentiment can be used to explain how an investor holding ACADIA can time the market purely based on public headlines and social activities around ACADIA Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of ACADIA Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about ACADIA Pharmaceuticals.
ACADIA Pharmaceuticals Implied Volatility | 0.74 |
ACADIA Pharmaceuticals' implied volatility exposes the market's sentiment of ACADIA Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ACADIA Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ACADIA Pharmaceuticals stock will not fluctuate a lot when ACADIA Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in ACADIA Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying ACADIA because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ACADIA Pharmaceuticals after-hype prediction price | USD 24.92 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current ACADIA contract
Based on the Rule 16, the options market is currently suggesting that ACADIA Pharmaceuticals will have an average daily up or down price movement of about 0.0463% per day over the life of the 2026-03-20 option contract. With ACADIA Pharmaceuticals trading at USD 25.13, that is roughly USD 0.0116 . If you think that the market is fully incorporating ACADIA Pharmaceuticals' daily price movement you should consider acquiring ACADIA Pharmaceuticals options at the current volatility level of 0.74%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out ACADIA Pharmaceuticals Basic Forecasting Models to cross-verify your projections. ACADIA Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of ACADIA Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ACADIA Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ACADIA Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ACADIA Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting ACADIA Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ACADIA Pharmaceuticals' historical news coverage. ACADIA Pharmaceuticals' after-hype downside and upside margins for the prediction period are 22.88 and 26.96, respectively. We have considered ACADIA Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ACADIA Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of ACADIA Pharmaceuticals is based on 3 months time horizon.
ACADIA Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as ACADIA Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ACADIA Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ACADIA Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 2.04 | 0.21 | 0.26 | 21 Events / Month | 7 Events / Month | In about 21 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
25.13 | 24.92 | 0.84 |
|
ACADIA Pharmaceuticals Hype Timeline
ACADIA Pharmaceuticals is presently traded for 25.13. The entity has historical hype elasticity of -0.21, and average elasticity to hype of competition of -0.26. ACADIA is forecasted to decline in value after the next headline, with the price expected to drop to 24.92. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.84%, whereas the daily expected return is presently at 0.21%. The volatility of related hype on ACADIA Pharmaceuticals is about 163.2%, with the expected price after the next announcement by competition of 24.87. About 99.0% of the company shares are held by institutions such as insurance companies. The book value of ACADIA Pharmaceuticals was presently reported as 5.42. The company last dividend was issued on the 30th of June 2010. Given the investment horizon of 90 days the next forecasted press release will be in about 21 days. Check out ACADIA Pharmaceuticals Basic Forecasting Models to cross-verify your projections.ACADIA Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to ACADIA Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict ACADIA Pharmaceuticals' future price movements. Getting to know how ACADIA Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ACADIA Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ADMA | ADMA Biologics | 0.26 | 12 per month | 2.58 | 0.05 | 5.01 | (4.27) | 13.78 | |
| PRAX | Praxis Precision Medicines | (3.51) | 8 per month | 3.95 | 0.17 | 9.33 | (6.06) | 36.21 | |
| LGND | Ligand Pharmaceuticals Incorporated | (2.38) | 10 per month | 2.03 | 0.01 | 3.51 | (2.76) | 18.09 | |
| BLTE | Belite Bio ADR | (0.99) | 24 per month | 2.69 | 0.23 | 7.96 | (5.94) | 18.84 | |
| SLNO | Soleno Therapeutics | (3.92) | 8 per month | 0.00 | (0.14) | 5.19 | (4.39) | 31.78 | |
| MIRM | Mirum Pharmaceuticals | 3.56 | 9 per month | 1.73 | 0.21 | 4.60 | (3.38) | 13.83 | |
| CRNX | Crinetics Pharmaceuticals | (0.06) | 11 per month | 2.29 | 0.11 | 4.38 | (4.63) | 19.30 | |
| DYN | Dyne Therapeutics | (0.37) | 11 per month | 4.71 | 0.04 | 7.01 | (5.90) | 58.12 | |
| VKTX | Viking Therapeutics | (1.17) | 27 per month | 0.00 | (0.05) | 7.49 | (5.49) | 19.06 | |
| IMVT | Immunovant | (3.92) | 30 per month | 2.14 | 0.14 | 5.31 | (3.63) | 20.44 |
ACADIA Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine ACADIA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ACADIA using various technical indicators. When you analyze ACADIA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ACADIA Pharmaceuticals Predictive Indicators
The successful prediction of ACADIA Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ACADIA Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ACADIA Pharmaceuticals based on analysis of ACADIA Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ACADIA Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ACADIA Pharmaceuticals's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 2.61 | 5.05 | 5.81 | 5.52 | Days Of Inventory On Hand | 285.89 | 97.89 | 112.57 | 199.95 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for ACADIA Stock analysis
When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |